Christina Kennedy

Christina Kennedy has a diverse work experience spanning multiple industries. Christina started their career as an Auditor at PricewaterhouseCoopers from 2004 to 2006. From 2006 to 2014, they worked at ViroPharma Incorporated, holding various roles including Finance Specialist and Manager of Forecasting and G&A Finance. Christina then joined Shire Pharmaceuticals (Acquired ViroPharma) as an Associate Director of Finance from 2014 to 2015. In 2016, they worked as a Finance Consultant for the Travis Manion Foundation before joining Aurinia Pharmaceuticals Inc. as the Head of Financial Planning and Analysis until 2020. From January 2020 onwards, they have served as the Vice President of Financial Planning and Analysis at Aurinia Pharmaceuticals Inc.

Christina Kennedy attended Penn State University from 2001 to 2004, where they obtained a Bachelor of Science (B.S.) degree in Accounting and International Business. In 2007, they obtained the Certified Public Accountant (CPA) certification from the National Association of State Boards of Accountancy.